Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Beneficiary Profile: The Florey

July 7, 2020
Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.
Read Transcript

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey Institute of Neuroscience and Mental Health (the Florey) study.  That’s why the Florey believes that everyone has a stake in health and medical research.

From mental health to epilepsy, stroke, dementia and basic discovery science, they are at the forefront of science's final frontier.

The Florey is the largest brain research group in the Southern Hemisphere and in the top 10 of the world’s best brain research centres.  In 1963, brothers Ken and Baillieu Myer, along with Ian Potter, worked with founding director, Derek Denton, to raise money to establish a medical research institute. This great act of philanthropy was the beginning of the Florey’s 55-year history and their connections to the community remain strong.

The Florey’s partnership with Hearts and Minds Investments Limited (HM1) is a testament to this wonderful collaborative spirit. As a celebrated member of the Florey Alumni community, Dr Mark Nelson is a former PhD student and lifelong Florey supporter. As Chair and Co-Founder of Caledonia Investments, Mark nominated the Florey as a beneficiary of HM1.

Today HM1 donates to the Florey encouraging the development of medicines and driving a new generation of medical research in Australia. The impact of this investment to the Florey's work is invaluable, as Mark notes, “Neuroscience is an area that the world really needs to focus on. Any investor will think very carefully about where they want their money to go. This initiative isn’t a band-aid. This aims at big ideas; at prevention and ways we can have far-reaching effects on human health. It’s almost at the stage that if we don’t fund brain research now and wait 20 years, we’ll look back and think ‘oh, that was a mistake. If only we’d done something at the time’.”

With thanks to Caledonia Investments and Hearts & Minds Investments Limited, Florey scientists continue to conduct important research in the area of brain and mind.

As part of our impact video series, we spoke with two key researchers at the Florey Institute for Neuroscience, discussing the importance of medical research and their recent breakthroughs. You can watch the video below.

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey Institute of Neuroscience and Mental Health (the Florey) study.  That’s why the Florey believes that everyone has a stake in health and medical research.

From mental health to epilepsy, stroke, dementia and basic discovery science, they are at the forefront of science's final frontier.

The Florey is the largest brain research group in the Southern Hemisphere and in the top 10 of the world’s best brain research centres.  In 1963, brothers Ken and Baillieu Myer, along with Ian Potter, worked with founding director, Derek Denton, to raise money to establish a medical research institute. This great act of philanthropy was the beginning of the Florey’s 55-year history and their connections to the community remain strong.

The Florey’s partnership with Hearts and Minds Investments Limited (HM1) is a testament to this wonderful collaborative spirit. As a celebrated member of the Florey Alumni community, Dr Mark Nelson is a former PhD student and lifelong Florey supporter. As Chair and Co-Founder of Caledonia Investments, Mark nominated the Florey as a beneficiary of HM1.

Today HM1 donates to the Florey encouraging the development of medicines and driving a new generation of medical research in Australia. The impact of this investment to the Florey's work is invaluable, as Mark notes, “Neuroscience is an area that the world really needs to focus on. Any investor will think very carefully about where they want their money to go. This initiative isn’t a band-aid. This aims at big ideas; at prevention and ways we can have far-reaching effects on human health. It’s almost at the stage that if we don’t fund brain research now and wait 20 years, we’ll look back and think ‘oh, that was a mistake. If only we’d done something at the time’.”

With thanks to Caledonia Investments and Hearts & Minds Investments Limited, Florey scientists continue to conduct important research in the area of brain and mind.

As part of our impact video series, we spoke with two key researchers at the Florey Institute for Neuroscience, discussing the importance of medical research and their recent breakthroughs. You can watch the video below.

Disclaimer: This material has been prepared by The Florey, published on July 7, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Picture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt Call
July 1, 2026

Next generation CAR T-cell therapy for cancer

The Call Lab at WEHI is pioneering innovative approaches to find this ‘goldilocks zone’, making CAR T-cell therapy safer and more effective.

Read More
Picture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale Cohen
July 1, 2026

Revolutionising Diabetes Care

Improving diabetes care has the potential to transform individual health outcomes while strengthening the wellbeing of entire communities.

Read More
HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).
May 4, 2026

How science turned back the clock of human development to create a miracle blood stem cell

Many thought it could never be done. But three Murdoch Children’s Research Institute scientists recreated embryonic development to crack the blood stem cell code.

Read More
November 15, 2024

Professor Alex Brown in conversation with Professor Jason Kovacic

At the 2024 Sohn Hearts & Minds Conference, we heard from Professor Alex Brown in conversation with Professor Jason Kovacic about Indigenous heart health and genomics.

Read More

A/Professor Tim Sargeant | 2024 Sohn Hearts & Minds Conference

Associate Professor Tim Sargeant has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide where he studies the role of lysosomes in Alzheimer’s disease.

Read More
July 1, 2026

Unlocking the mysteries of the human brain

The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.

Read More
Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.
July 1, 2026

A new approach to Parkinson’s Disease

Exploring nerve stimulation as a potential treatment.

Read More
Dr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds Conference
July 1, 2026

Revealing what drives PSP

Mapping the biological changes behind progressive supranuclear palsy in the brain.

Read More
Picture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer Snaith
July 1, 2026

Advancing treatment options for type 1 diabetes

Improving blood glucose and reducing insulin needs.

Read More
Picture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish King
July 1, 2026

Solving the genetic causes of autoimmune diseases

Mapping hundreds of risk markers to better understand how these diseases develop and progress

Read More
July 1, 2026

The Future of Pain Management

Enhancing healthcare professionals' ability to deliver better pain management, now and into the future.

Read More
July 1, 2026

Harnessing the power of stem cell technology

Developing cell therapies for patients with blood diseases

Read More
Picture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki Negishi
July 1, 2026

Protecting the heart when every minute matters

Investigating a new treatment to reduce heart damage after heart attacks

Read More
Picture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio Vittorio
July 1, 2026

Targeting the drivers of cancer growth

Exploring how extrachromosomal DNA (ecDNA) drives cancer growth, spread and treatment resistance.

Read More
July 1, 2026

Improving the diagnosis of muscle disorders using advanced genetic testing

Focused on improving the efficiency and accuracy of diagnosing muscle disorders.

Read More